Swedish Orphan Biovitrum AB (B6E)

watchoutny

This is why 1 day gains don't impress me!!

Been following this guy for a while. He is usually right!!!
https://x.com/MikeFra52981086/status/2067660228254929174?s=20

If BCBC went up a penny every time you posted about it, it would be well over $2!!!!!!!!!!!!!!!

$ADMQ ADM Endeavors Strengthens Leadership and Growth Team With Appointment of Chief Financial Officer and Addition of Senior Sales TalentNew Media Wire | 06/16/2026 https://www.otcmarkets.com/stock/admq/overview

Burst baskets started and shares to short dropped from 4.4m yesterday to 1.9m (at open today) continued dropping to 1.3m now .

AW was counting on one of the top 10 pharma companies buying this junk out long ago. He probably thought J&J would be the one.

All this company needs is someone with 40 million for advertising to take a chance, that's all.

MDCX.....EXFY......AIIO.......GCTS......NIXX.......CCHH....................https://stockcharts.com/sc3/ui/?s=CCHH&p=d&yr=0&mn=2&dy=12&id=p84071410134

.0004s going now - multiple bidders .0350 > .0355 about to get left behind when it goes straight to .0485

Been a great swing/day trade, for me anyways. Will gladly take more on another dip 🚀

Yah maybe they have some white label services deals where profit sharing is taking place and that’s returned to shareholders in the dividends cause mgmt wants paid too. But yeah could make sense to save and buy more or scale more … who knows I guess but yah if the dividend actually happens this shou

Posted on behalf of Pacific Ridge Exploration Corp. - PEX's Yukon assets are getting a significant exploration push while the company remains focused on its BC copper portfolio.

Under its option agreement, Labrador Gold can earn 100% of Mariposa and Eureka Dome by spending $5.4M over

Drove this truck from Canada to Las Vegas
https://www.powerprogress.com/news/westport-shows-highpressure-cng-fuel-system-at-act-expo/8120988.article?zephr_sso_ott=0g1khy

RSV competition Shionogi

Here is the trial listing:
https://clinicaltrials.gov/study/NCT07214571


Reminder this an L inhibitor like EDP-323, in phase 2b real world HR adult study. Started enrolling 7 months ago and targeting completion end of this year

I think it's important to keep watching what Marvell posts and puts out... as ex-Polariton leaders are working there getting Perkinamine to produce what's needed. So, I check on it on LinkedIn and see a lot happening such as with the following post:

https://www.linkedin.com/company/m

there goes that million share trade again, is this the third of fourth day in a row that we have had that ?

Going to zero!! 

Any updates?

that is what you have. That is your diligence rebuttal. Those are your numbers and your documented sources? O.k.

Couldn't tell. Missed it. Was too busy with something else. This is .0015 x .0020 now.

OH BABY!

I agree.
..and ALL ... (did I mention all...) things are possible

.. FTICJ

100%. I am waiting for the floodgates to open on the bid.

Jetmek, Good correction, and I'll take it — this is the right kind of pushback.

You're correct that a plain rights offering reconciles within the rights CUSIP, not the common, and that a broker short on rights just buys rights to flatten. The reconciliation at the subscription-agent l